← Open Payments lookup

MARY PORTER: Open Payments

NPI 1356489272 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,225 in 75 payments from 17 companies in 2025. Trend: 2023 $791 · 2024 $912 · 2025 $1,225

Food & beverage: $1,225
CompanyPaymentsAmount
ABBVIE INC.20$215
PFIZER INC.10$156
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$147
Astellas Pharma US Inc6$133
Novo Nordisk Inc4$79
Ardelyx, Inc.3$76
Takeda Pharmaceuticals U.S.A., Inc.4$74
Otsuka America Pharmaceutical, Inc.4$72
AstraZeneca Pharmaceuticals LP3$62
Axsome Therapeutics, Inc.2$41

Products named: CAPLYTA, Veozah, UBRELVY, NURTEC ODT, VRAYLAR, Ozempic, IBSRELA, TRINTELLIX.

Industry payments across MS — which companies pay providers there.